MHLW Orders Label Revisions for Dexamethasone, Betamethasone to Warn of Phaeochromocytoma Crisis

May 16, 2022
The Ministry of Health, Labor and Welfare (MHLW) on May 13 ordered label revisions for drugs containing dexamethasone- or betamethasone-related steroids, calling for the addition of a warning regarding the risk of phaeochromocytoma crisis in patients taking these medicines. The...read more